Glucagon-like peptide-1 levels and dipeptidyl peptidase-4 activity in type 2 diabetes

SENYIGIT A., Tabak O., ORBANOGLU T., Karadag A., Ugurlu S., Uzun H., ...Daha Fazla

CLINICAL AND INVESTIGATIVE MEDICINE, cilt.40, sa.5, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 40 Sayı: 5
  • Basım Tarihi: 2017
  • Doi Numarası: 10.25011/cim.v40i5.28624
  • Dergi Adı: CLINICAL AND INVESTIGATIVE MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • İstanbul Üniversitesi Adresli: Evet

Özet

Purpose: Hyperglycemia is the major risk factor for microvascular complications in type 2 diabetes mellitus (T2DM) patients. This randomized controlled clinical trial aimed to investigate T2DM patients with microvascular complications with regard to possible relations among serum clusterin (CLU), amylin, secreted frizzled-related protein-4 (SFRP-4), glucagon-like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP-4) activities.